Aldosterone breakthrough caused by chronic blockage of angiotensin II type 1 receptors in human adrenocortical cells: Possible involvement of bone morphogenetic protein-6 actions

Endocrinology

Volumn 149, Issue 6, 2008, Pages 2816-2825

  Otani, Hiroyuki ^a   Otsuka, Fumio ^a   Inagaki, Kenichi ^a   Suzuki, Jiro ^a   Miyoshi, Tomoko ^a   Kano, Yoshihiro ^a   Goto, Junko ^a   Ogura, Toshio ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; BONE MORPHOGENETIC PROTEIN 6; CANDESARTAN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; POTASSIUM; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ADRENAL CORTEX CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ADRENAL CORTEX; ALDOSTERONE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BONE MORPHOGENETIC PROTEINS; CELL LINE; GENES, REPORTER; HUMANS; IMMUNOHISTOCHEMISTRY; KINETICS; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRAZOLES; TRANSFECTION;

EID: 44249096797     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1476     Document Type: Article

References (36)

1. Foster RH, MacFarlane CH, Bustamante MO 1997 Recent progress in understanding aldosterone secretion. Gen Pharmacol 28:647-651
2. Lumbers ER 1999 Angiotensin and aldosterone. Regul Pept 80:91-100
3. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP 1998 Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 19:101-143
4. Suzuki J, Otsuka F, Inagaki K, Takeda M, Ogura T, Makino H 2004 Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells. Endocrinology 145:639-649
5. Otsuka F, Yao Z, Lee TH, Yamamoto S, Erickson GF, Shimasaki S 2000 Bone morphogenetic protein-15: Identification of target cells and biological functions. J Biol Chem 275:39523-39528
6. Shimasaki S, Moore RK, Otsuka F, Erickson GF 2004 The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25:72-101
7. Otsuka F, Moore RK, Shimasaki S 2001 Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem 276:32889-32895
8. Takeda M, Otsuka F, Suzuki J, Kishida M, Ogura T, Tamiya T, Makino H 2003 Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas. Biochem Biophys Res Commun 306:812-818
9. Otsuka F, Shimasaki S 2002 A novel function of bone morphogenetic protein-15 in the pituitary: selective synthesis and secretion of FSH by gonadotropes. Endocrinology 143:4938-4941
10. Suzuki J, Otsuka F, Takeda M, Inagaki K, Miyoshi T, Mimura Y, Ogura T, Doihara H, Makino H 2005 Functional roles of the bone morphogenetic protein system in thyrotropin signaling in porcine thyroid cells. Biochem Biophys Res Commun 327:1124-1130
11. Kano Y, Otsuka F, Takeda M, Suzuki J, Inagaki K, Miyoshi T, Miyamoto M, Otani H, Ogura T, Makino H 2005 Regulatory roles of bone morphogenetic proteins and glucocorticoids in catecholamine production by rat pheochromocytoma cells. Endocrinology 146:5332-5340
12. Inagaki K, Otsuka F, Suzuki J, Kano Y, Takeda M, Miyoshi T, Otani H, Mimura Y, Ogura T, Makino H 2006 Involvement of bone morphogenetic protein-6 in differential regulation of aldosterone production by angiotensin II and potassium in human adrenocortical cells. Endocrinology 147:2681-2689
13. Staessen J, Lijnen P, Fagard R, Verschueren LJ, Amery A 1981 Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol 91:457-465
14. Lijnen P, Staessen J, Fagard R, Amery A 1982 Increase in plasma aldosterone during prolonged captopril treatment. Am J Cardiol 49:1561-1563
15. Naruse M, Tanabe A, Sato A, Takagi S, Tsuchiya K, Imaki T, Takano K 2002 Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats. Hypertension 40:28-33
16. Sato A, Saruta T 2001 Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy. J Int Med Res 29:13-21
17. Sato A, Hayashi K, Naruse M, Saruta T 2003 Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 41:64-68
18. Sato A, Saruta T 2003 Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy. Am J Hypertens 16:781-788
19. Moore RK, Otsuka F, Shimasaki S 2003 Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem 278:304-310
20. Inagaki K, Otsuka F, Suzuki J, Otani H, Takeda M, Kano Y, Miyoshi T, Yamashita M, Ogura T, Makino H 2007 Regulatory expression of bone morphogenetic protein-6 system in aldosterone production by human adrenocortical cells. Regul Pept 138:133-140
21. Miyoshi T, Otsuka F, Suzuki J, Takeda M, Inagaki K, Kano Y, Otani H, Mimura Y, Ogura T, Makino H 2006 Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells. Biol Reprod 74:1073-1082
22. Otani H, Otsuka F, Inagaki K, Takeda M, Miyoshi T, Suzuki J, Mukai T, Ogura T, Makino H 2007 Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation. Am J Physiol Renal Physiol 292:F1513-F1525
23. Horita Y, Taura K, Taguchi T, Furusu A, Kohno S 2006 Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy. Nephrology (Carlton) 11:462-466
24. Bomback AS, Klemmer PJ 2007 The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol 3:486-492
25. MacFadyen RJ, Lee AF, Morton JJ, Pringle SD, Struthers AD 1999 How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? Heart 82:57-61
26. Mizuno Y, Yoshimura M, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, Harada E, Nakayama M, Nakamura S, Ito T, Shimasaki Y, Saito Y, Nakao K 2001 Aldosterone production is activated in failing ventricle in humans. Circulation 103:72-77
27. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H 1994 Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 269:24316-24320
28. Ahmad N, Romero DG, Gomez-Sanchez EP, Gomez-Sanchez CE 2004 Do human vascular endothelial cells produce aldosterone? Endocrinology 145:3626-3629
29. Spat A, Hunyady L 2004 Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84:489-539
30. Johns DW, Baker KM, Ayers CR, Vaughan Jr ED, Carey RM, Peach MJ, Yancey MR, Ortt EM, Williams SC 1980 Acute and chronic effect of captopril in hypertensive patients. Hypertension 2:567-575
31. Okubo S, Niimura F, Nishimura H, Takemoto F, Fogo A, Matsusaka T, Ichikawa I 1997 Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion. J Clin Invest 99:855-860
32. Jorde UP, Vittorio T, Katz SD, Colombo PC, Latif F, Le Jemtel TH 2002 Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. Circulation 106:1055-1057
33. Bird IM, Mason JI, Rainey WE 1994 Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. Endocrinology 134:2468-2474
34. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ 1992 Plasma endothelin in chronic heart failure. Circulation 85:1374-1379
35. Rossi GP 2006 Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists? Curr Hypertens Rep 8:262-268
36. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM 2005 Distinct roles for the kidney and systemic tissues in blood pressure regulation by the reninan-giotensin system. J Clin Invest 115:1092-1099